EUVIMEDEUVIMED entdecken
Crossref

Increase in Sialylated EGFR Levels by Arsenite Enhances EGF‐Dependent EGFR Phosphorylation

Daigo Sumi iD, Saho Nakahira, Hiroki Taguchi, Ayako Nakayama, Rina Nakayama, Hitomi Fujishiro

Journal of Applied Toxicology · 21.06.2026

DOI: 10.1002/jat.70308 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Applied Toxicology, online erschienen am 21.06.2026. Verfasst von Daigo Sumi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmaceutical Sciences, Tokushima Bunri University Yamashiro-cho, Tokushima, Japan. Die Arbeit nennt 36 Literaturangaben. Gefördert von: JSPS KAKENHI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although the carcinogenicity of arsenic compounds is well established, the underlying mechanisms remain poorly understood. Cancer cells are known to evade natural killer (NK) cell–mediated cytotoxicity by presenting sialic acids at the termini of cell‐surface glycans, and aberrant sialylation of specific proteins has been implicated in cancer progression. In this study, building on our previous finding that arsenite (As(III)) exposure increases cell‐surface sialic acid levels, we investigated whether As(III) exposure alters the levels of sialylated epidermal growth factor receptor (EGFR) and whether these changes affect downstream signal transduction. We first confirmed that EGFR expressed in A431 cells is modified with α 2–6–linked sialic acid. When A431 cells were exposed to As(III), sialylated EGFR levels increased markedly. Treatment of A431 cells with sialidase significantly suppressed EGF‐dependent EGFR phosphorylation, indicating that sialylated EGFR positively regulates EGF‐induced EGFR phosphorylation in A431 cells. Exposure to As(III) markedly enhanced EGF‐dependent phosphorylation of EGFR and showed a tendency to increase phosphorylation of the downstream signaling molecule ERK; however, sialidase treatment completely abolished this enhancement. Taken together, these results demonstrate that As(III) activates the EGF‐induced phosphorylation cascade by promoting EGFR sialylation.

Schlagwörter

Stichwörter der Autor:innen

EGFRarsenicphosphorylationsialic acid

Autor:innen und Institutionen

  • Faculty of Pharmaceutical Sciences, Tokushima Bunri University Yamashiro-cho, Tokushima, Japan.
  • Laboratory of Molecular Biology, Metabolism, Graduate School of Pharmaceutical Sciences Tohoku University, Sendai, Miyagi, Japan.

ORCID-Profile: Daigo Sumi

Förderung

  • JSPS KAKENHI

Zitieren

APA

Sumi, D., Nakahira, S., Taguchi, H., Nakayama, A., Nakayama, R., & Fujishiro, H. (2026). Increase in Sialylated EGFR Levels by Arsenite Enhances EGF‐Dependent EGFR Phosphorylation. Journal of Applied Toxicology. https://doi.org/10.1002/jat.70308

Vancouver

Sumi D, Nakahira S, Taguchi H, Nakayama A, Nakayama R, Fujishiro H. Increase in Sialylated EGFR Levels by Arsenite Enhances EGF‐Dependent EGFR Phosphorylation. Journal of Applied Toxicology. 2026. doi:10.1002/jat.70308

BibTeX
@article{Sumi2026,
  author = {Sumi, Daigo and Nakahira, Saho and Taguchi, Hiroki and Nakayama, Ayako and Nakayama, Rina and Fujishiro, Hitomi},
  title = {Increase in Sialylated EGFR Levels by Arsenite Enhances EGF‐Dependent EGFR Phosphorylation},
  journal = {Journal of Applied Toxicology},
  year = {2026},
  doi = {10.1002/jat.70308}
}
Kostenlos starten →